{"nct_id":"NCT00137917","title":"Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs","status":"COMPLETED","status_verified_date":"2016-09","start_date":"2002-07","start_date_type":null,"primary_completion_date":"2003-06","primary_completion_date_type":"ACTUAL","completion_date":"2003-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}